We are live on ! Find out more
BCM

BIOS Capital Management Portfolio holdings

AUM $52.9M
1-Year Est. Return 30.51%
This Fund
S&P 500
This Quarter Est. Return
-15.06%
1 Year Est. Return
+30.51%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$79.2M
AUM Growth
-$14.9M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACTU
1
Actuate Therapeutics
ACTU
$26.6M
$67M 84.59%
9,893,651
LTRN icon
2
Lantern Pharma
LTRN
$33.6M
$4.28M 5.4%
1,207,709
RNTX
3
Rein Therapeutics
RNTX
$63.1M
$2.99M 3.78%
1,690,751
CGTX icon
4
Cognition Therapeutics
CGTX
$79.6M
$2.52M 3.19%
6,000,000
INAB icon
5
IN8bio
INAB
$9.88M
$1.43M 1.8%
286,667
IRD
6
Opus Genetics
IRD
$306M
$977K 1.23%
995,249

Similar funds

BIOS Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, BIOS Capital Management held 6 positions worth $79.2M, down 16% from $94.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 0%. BIOS Capital Management opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • BIOS Capital Management's ten largest holdings make up 100% of its $79.2M portfolio in Q1 2025.
  • BIOS Capital Management opened 0 new positions and closed 0 in Q1 2025.
  • BIOS Capital Management's portfolio value fell 16% quarter-over-quarter to $79.2M.

Based on BIOS Capital Management's 13F filing for Q1 2025, filed 14 May 2025.